CHARACTERIZATION OF A SMALL-CELL-LUNG-CARCINOMA CELL-LINE FROM A PATIENT WITH CANCER-ASSOCIATED RETINOPATHY
Citation
Y. Yamaji et al., CHARACTERIZATION OF A SMALL-CELL-LUNG-CARCINOMA CELL-LINE FROM A PATIENT WITH CANCER-ASSOCIATED RETINOPATHY, International journal of cancer, 65(5), 1996, pp. 671-676
Categorie Soggetti
Oncology
SICI code
0020-7136(1996)65:5<671:COASCF>2.0.ZU;2-D
Abstract
We examined the biologic properties of a small-cell-lung-carcinoma (SC
LC) cell line (designated MN-1112) established from a patient with SCL
C who showed paraneoplastic retinopathy syndrome. Morphologic and immu
nocytochemical analyses showed that MN-1112 cells possess features of
the classic type of SCLC. MN-1112 cells grew in suspension forming rel
atively large clumps of cells with a doubling time of 72 hr. By light-
microscope examination, the cells were relatively small and had scanty
cytoplasm. The cells produced NSE, ACTH and CK (BE isozyme); they als
o expressed recoverin, a novel photoreceptor protein, detected by Nort
hern-blot and Western-immunoblot analysis using human-recoverin-specif
ic DNA probe and anti-bovine-recoverin polyclonal antibody. This repor
t shows that human recoverin is expressed in cultured SCLC cells. Our
results support the hypothesis that, in cancer-associated retinopathy
(CAR) patients, auto-immune antibody targeting for ectopic recoverin i
n SCLC is initially produced and cross-reacts with the retinal protein
, resulting in the retinal degeneration that occurs in CAR patients. (
C) 1996 Wiley-Liss, Inc.